Logo image of ELMS

Electric Last Mile Solutions Inc (ELMS) Stock Fundamental Analysis

NASDAQ:ELMS - US28489L1044 - Common Stock

0.1884
-0.1 (-34.97%)
Last: 6/22/2022, 8:19:53 PM
0.1773
-0.01 (-5.89%)
After Hours: 6/22/2022, 8:19:53 PM
Fundamental Rating

1

ELMS gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 37 industry peers in the Automobiles industry. ELMS may be in some trouble as it scores bad on both profitability and health. ELMS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ELMS had negative earnings in the past year.
ELMS Yearly Net Income VS EBIT VS OCF VS FCFELMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 -5M -10M -15M -20M -25M

1.2 Ratios

Industry RankSector Rank
ROA -15.33%
ROE N/A
ROIC -9.18%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ELMS Yearly ROA, ROE, ROICELMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 -2 -4 -6 -8 -10

1.3 Margins

ELMS does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) -42257.14%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ELMS Yearly Profit, Operating, Gross MarginsELMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELMS is destroying value.
Compared to 1 year ago, ELMS has about the same amount of shares outstanding.
ELMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ELMS Yearly Shares OutstandingELMS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 10M 20M 30M
ELMS Yearly Total Debt VS Total AssetsELMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 50M 100M 150M 200M 250M

2.2 Solvency

ELMS has an Altman-Z score of 0.08. This is a bad value and indicates that ELMS is not financially healthy and even has some risk of bankruptcy.
ELMS has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 0.08
ROIC/WACC-0.86
WACC10.62%
ELMS Yearly LT Debt VS Equity VS FCFELMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 50M 100M 150M 200M

2.3 Liquidity

ELMS has a Current Ratio of 2.58. This indicates that ELMS is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 2.48 indicates that ELMS has no problem at all paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.48
ELMS Yearly Current Assets VS Current LiabilitesELMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 1M 2M 3M

More info and screens

1

3. Growth

3.1 Past

ELMS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1359216.20%.
EPS 1Y (TTM)-1359216.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4580.6%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

ELMS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.15% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y28.87%
EPS Next 2Y-5.42%
EPS Next 3Y22.14%
EPS Next 5Y12.15%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ELMS Yearly Revenue VS EstimatesELMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 1B 2B 3B
ELMS Yearly EPS VS EstimatesELMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

ELMS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ELMS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ELMS Price Earnings VS Forward Price EarningsELMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ELMS Per share dataELMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

A more expensive valuation may be justified as ELMS's earnings are expected to grow with 22.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-5.42%
EPS Next 3Y22.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ELMS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Electric Last Mile Solutions Inc

NASDAQ:ELMS (6/22/2022, 8:19:53 PM)

After market: 0.1773 -0.01 (-5.89%)

0.1884

-0.1 (-34.97%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)03-01 2022-03-01/bmo
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap23.37M
Analysts50
Price Target15.3 (8021.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 166.91
P/FCF N/A
P/OCF N/A
P/B 0.09
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.21
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS2.17
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -15.33%
ROE N/A
ROCE N/A
ROIC -9.18%
ROICexc N/A
ROICexgc -9.36%
OM N/A
PM (TTM) -42257.14%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.48
Altman-Z 0.08
F-Score3
WACC10.62%
ROIC/WACC-0.86
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1359216.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4580.6%
EPS Next Y28.87%
EPS Next 2Y-5.42%
EPS Next 3Y22.14%
EPS Next 5Y12.15%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A